Acadian Asset Management’s Passage Bio PASG Stock Holding History
Bought
Maintained
Sold
Other funds holding PASG
LCM
IC
EAM
VA
Acadian Asset Management's PASG Position: Q2 2026 in Review
Acadian Asset Management reduced its Passage Bio (PASG) stake by 7% in Q2 2026, selling an estimated $10.6K and leaving 22,496 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #1740.
Acadian Asset Management first reported a position in PASG in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.3M in Q1 2024. 28 funds tracked by Wall St. Rank hold PASG as of Q2 2026.
- Acadian Asset Management held 22,496 shares of Passage Bio worth $109K as of Q2 2026.
- Acadian Asset Management sold 1,700 Passage Bio shares in Q2 2026, an estimated $10.6K.
- Passage Bio made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1740 holding.
- Acadian Asset Management first reported a position in Passage Bio in Q1 2022 and has held it in 18 quarters since.
- Acadian Asset Management's Passage Bio position peaked at $1.3M in Q1 2024.
- 28 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.